Acadian Asset Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73K Buy
12,853
+4,375
+52% +$25.1K ﹤0.01% 1812
2026
Q1
$52K Buy
+8,478
New +$78.7K ﹤0.01% 1850
2024
Q4
– Sell
-5,415
Closed -$41K – 2020
2024
Q3
$41K Buy
+5,415
New +$48.1K ﹤0.01% 1855
2024
Q2
– Sell
-24,562
Closed -$297K – 1872
2024
Q1
$297K Sell
24,562
-20,307
-45% -$294K ﹤0.01% 1115
2023
Q4
$641K Buy
+44,869
New +$431K ﹤0.01% 968
2023
Q3
– Sell
-2,799
Closed -$39K – 1784
2023
Q2
$39K Buy
+2,799
New +$39.9K ﹤0.01% 1555
2021
Q1
– Sell
-14
Closed – – 2246
2020
Q4
$0 Hold
14
– – ﹤0.01% 2312
2020
Q3
$0 Hold
14
– – ﹤0.01% 2308
2020
Q2
$0 Hold
14
– – ﹤0.01% 2304
2020
Q1
$0 Hold
14
– – ﹤0.01% 1896
2019
Q4
$0 Hold
14
– – ﹤0.01% 2018
2019
Q3
$0 Hold
14
– – ﹤0.01% 1971
2019
Q2
$0 Sell
14
-2,815
-100% -$38K ﹤0.01% 1985
2019
Q1
$36K Sell
2,829
-2,089
-42% -$27.2K ﹤0.01% 1738
2018
Q4
$54K Buy
4,918
+200
+4% +$2.96K ﹤0.01% 1413
2018
Q3
$85K Buy
+4,718
New +$59.4K ﹤0.01% 1245

Other funds holding OPRX

Acadian Asset Management's OPRX Position: Q2 2026 in Review

Acadian Asset Management increased its OptimizeRx (OPRX) stake by 52% in Q2 2026, buying an estimated $25.1K and bringing the position to 12,853 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Acadian Asset Management first reported a position in OPRX in Q3 2018 and has held it in 16 quarters since. The position peaked at $641K in Q4 2023. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Acadian Asset Management held 12,853 shares of OptimizeRx worth $73K as of Q2 2026.
  • Acadian Asset Management bought 4,375 OptimizeRx shares in Q2 2026, an estimated $25.1K.
  • OptimizeRx made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1812 holding.
  • Acadian Asset Management first reported a position in OptimizeRx in Q3 2018 and has held it in 16 quarters since.
  • Acadian Asset Management's OptimizeRx position peaked at $641K in Q4 2023.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.